| Code | Description | Claims | Beneficiaries | Total Paid |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,258 |
12,205 |
$2.13M |
| 80053 |
Comprehensive metabolic panel |
10,069 |
8,411 |
$518K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,564 |
1,740 |
$341K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
4,570 |
1,057 |
$332K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
748 |
641 |
$319K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
9,614 |
8,001 |
$258K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,334 |
866 |
$242K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,325 |
3,811 |
$206K |
| 81001 |
|
4,381 |
3,644 |
$147K |
| 70450 |
Computed tomography, head or brain; without contrast material |
434 |
349 |
$136K |
| 80061 |
Lipid panel |
2,694 |
2,489 |
$133K |
| 87428 |
|
2,936 |
2,517 |
$129K |
| 83605 |
|
2,226 |
1,827 |
$124K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,490 |
3,047 |
$112K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,724 |
2,176 |
$110K |
| 36415 |
Collection of venous blood by venipuncture |
7,701 |
6,456 |
$108K |
| 71045 |
Radiologic examination, chest; single view |
1,723 |
1,398 |
$93K |
| 71046 |
Radiologic examination, chest; 2 views |
1,091 |
984 |
$90K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,061 |
939 |
$82K |
| 84484 |
|
2,580 |
1,962 |
$77K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
1,879 |
1,767 |
$75K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
1,324 |
1,082 |
$69K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,186 |
947 |
$67K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
403 |
328 |
$66K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,020 |
809 |
$64K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
735 |
686 |
$61K |
| 82550 |
|
2,171 |
1,772 |
$60K |
| 83735 |
|
2,213 |
1,821 |
$59K |
| 82553 |
|
1,321 |
1,124 |
$58K |
| 87088 |
|
1,392 |
1,161 |
$53K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
597 |
456 |
$50K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,370 |
1,201 |
$50K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
749 |
226 |
$47K |
| 85610 |
|
1,834 |
1,372 |
$45K |
| 82607 |
|
646 |
607 |
$45K |
| 85027 |
|
1,166 |
967 |
$44K |
| 85007 |
|
1,150 |
952 |
$40K |
| 87420 |
|
734 |
616 |
$38K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,772 |
2,357 |
$38K |
| 85730 |
|
1,297 |
1,037 |
$37K |
| 83690 |
|
804 |
655 |
$35K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,367 |
1,806 |
$34K |
| 80306 |
|
314 |
261 |
$30K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
715 |
589 |
$29K |
| 85378 |
|
689 |
588 |
$29K |
| 87040 |
|
574 |
331 |
$25K |
| 82150 |
|
577 |
472 |
$24K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
688 |
560 |
$24K |
| 84439 |
|
508 |
472 |
$23K |
| 87631 |
|
130 |
113 |
$21K |
| 83880 |
|
374 |
335 |
$17K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
315 |
275 |
$16K |
| 81025 |
|
326 |
287 |
$16K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
99 |
77 |
$15K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
410 |
308 |
$13K |
| 86140 |
|
538 |
448 |
$13K |
| 87077 |
|
425 |
347 |
$13K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
132 |
95 |
$12K |
| 80050 |
General health panel |
89 |
81 |
$11K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
644 |
564 |
$11K |
| 87186 |
|
359 |
305 |
$10K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
61 |
58 |
$9K |
| 86141 |
|
248 |
211 |
$9K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
249 |
193 |
$9K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
62 |
29 |
$8K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
294 |
250 |
$8K |
| 82570 |
|
256 |
230 |
$8K |
| 82803 |
|
146 |
122 |
$8K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
319 |
250 |
$7K |
| 84481 |
|
123 |
113 |
$7K |
| 82043 |
|
182 |
161 |
$7K |
| 97014 |
|
122 |
31 |
$6K |
| 74018 |
|
74 |
67 |
$6K |
| 97162 |
|
68 |
62 |
$5K |
| 85651 |
|
247 |
218 |
$4K |
| 73630 |
|
46 |
42 |
$4K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
972 |
865 |
$4K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
609 |
551 |
$2K |
| 97035 |
|
47 |
12 |
$2K |
| 71250 |
|
17 |
12 |
$2K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
304 |
200 |
$2K |
| 73610 |
|
19 |
18 |
$2K |
| 73564 |
|
16 |
13 |
$2K |
| 87070 |
|
51 |
46 |
$2K |
| 36600 |
|
41 |
27 |
$1K |
| 72100 |
|
13 |
12 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
85 |
78 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
45 |
45 |
$917.20 |
| 83655 |
|
14 |
14 |
$498.00 |
| 84482 |
|
13 |
12 |
$471.52 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
31 |
29 |
$387.17 |
| 87081 |
|
12 |
12 |
$378.00 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
100 |
77 |
$376.85 |
| J7050 |
Infusion, normal saline solution, 250 cc |
30 |
28 |
$265.64 |
| 99307 |
|
21 |
13 |
$0.00 |